Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.
about
Fatigue Management in Multiple SclerosisAssessing Four Quality Indicators for Multiple Sclerosis Management Through Patient-Reported DataChildren and adolescents adjustment to parental multiple sclerosis: a systematic reviewPatient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort.Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medicationInternational Differences in Multiple Sclerosis Health Outcomes and Associated Factors in a Cross-sectional SurveyFatigue in multiple sclerosis: mechanisms, evaluation, and treatmentHealth-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.Randomized controlled trial of a teleconference fatigue management plus physical activity intervention in adults with multiple sclerosis: rationale and research protocol.Quality of life in multiple sclerosis.Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis.Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosisClinically significant fatigue: prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internetTreatment satisfaction, adherence and behavioral assessment in patients de-escalating from natalizumab to interferon βEffectiveness of glatiramer acetate compared to other multiple sclerosis therapiesAntiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis.Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disabilityComparison of the psychometric properties of two fatigue scales in multiple sclerosisMS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial.Tracking daily fatigue fluctuations in multiple sclerosis: ecological momentary assessment provides unique insights.Adherence to monthly online self-assessments for short-term monitoring: a 1-year study in relapsing-remitting multiple sclerosis patients after start of disease modifying treatment.Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort.Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics.Predictors of Fatigue Impact in Persons With Long-Standing Multiple SclerosisAssociation of fish consumption and Ω 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis.Prevalence of fatigue in patients with multiple sclerosis and its effect on the quality of life.Developing a wellness program for people with multiple sclerosis: description and initial results.Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.Benefits of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis.Physical activity in subjects with multiple sclerosis with focus on gender differences: a survey.Quality of life in multiple sclerosis: effects of current treatment options.Multiple sclerosis-associated fatigue.Fatigue in healthy and diseased individuals.Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.Meta-analysis of adverse events in recent randomized clinical trials for dimethyl fumarate, glatiramer acetate and teriflunomide for the treatment of relapsing forms of multiple sclerosis.Understanding fatigue in paediatric multiple sclerosis: a systematic review of clinical and psychosocial factors.Translating Fatigue to Human Performance.Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis.Quality of life among people with multiple sclerosis: Replication of a three-factor prediction model.
P2860
Q26752946-DABA7042-AFFD-4D84-8185-44202A875DA3Q31123075-549792C0-AF4C-4F91-B9C1-F3A4B13D3727Q33694029-A5550A29-CE94-4F2A-B495-6DAAE80D2770Q33712460-21B7EDB1-D1C8-42B9-9B5B-FBA839AE3BB4Q33735739-72773419-E9FE-41E1-8CC6-92F65CE638BBQ33742328-C487D929-7DF7-43D2-A222-FB07BD9FC159Q34021881-8846EBEC-448B-41F4-B00C-7412D74D52CDQ34393224-4F068785-F956-49FE-AFCB-965E1A1233DAQ34448537-58BE200C-564A-4E17-B625-58CAC646EAA6Q34481312-CDC126BB-1C01-4AAA-9DFC-F5909E50A205Q34677081-3A2DFEB0-1B67-4DD3-B8F5-DB241216061EQ34687024-8375BCCE-AE41-4839-AB97-15DEE605FE8BQ35097889-AFFCC12F-5F77-4EC5-9DAB-EA9BDE08D5B7Q35103997-8FDF9801-C808-4AF4-8A13-C95115BD23C3Q35743570-30EA9BB9-D60C-41B2-8841-66A8CBECCF1FQ35843867-356E5E2C-523D-4E1F-9E16-41D25232005BQ35866381-8781ADFD-ED8B-4AB4-B280-E3778A92FC28Q36174605-FA8E516D-B5D4-4293-A68F-658A7A185D03Q36293816-2918E936-0C46-4D7E-A568-CBB83070B87AQ36303789-8B043DF9-C59F-4F4B-9354-9B1DD0F86B9AQ36761902-00B13A65-917D-4D8F-AAAD-80E2794B0373Q36777636-8ED8FE36-E9AC-4647-A5C8-0BE8964061A2Q36830898-0B165DD7-76F3-41C8-8C81-198FE71FFFCAQ36860594-47041FC0-9636-4AB7-A6A7-CA64D0C0420BQ37290620-CC43B713-B163-4376-9B36-C2E7E4D662DFQ37290749-3F947BD0-F9B2-41E7-9796-1013524A80ABQ37442117-62A43569-E200-4C32-8E0C-F9D5FC3FBC17Q37442396-99556DD1-125C-4052-90A5-679B6048CE65Q37519608-599EA552-1992-41BA-8D12-6FF8814A3940Q37684368-AEDFDE89-2BBA-4508-B056-1619FB5CA20DQ37710122-7F4C7F70-740F-48BB-AD2A-5E98A8613E3CQ37785555-6934623C-3AAE-4130-875D-189FC2D4EFE4Q38124676-01862140-A659-45AD-8F85-D427AE850583Q38238548-8DE62C20-FB4D-401D-B445-6DEC808C6D00Q38267110-18042F8B-4122-4422-8F6C-9C6B0EF7F5DBQ38632953-A8132252-34CF-45AF-B4B2-2E93E16A2C04Q38789024-B4956944-DF9E-4F9A-9928-F0EE05A0B687Q38855448-C9523724-6F34-4E04-B858-58FC1F42C948Q39672574-D4A206D1-FB2B-4659-B768-439D49E1DBC4Q40240777-95BDDEAE-4F82-4FBE-8D8F-57C52D4ACCAE
P2860
Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Fatigue characteristics in mul ...... le Sclerosis (NARCOMS) survey.
@en
Fatigue characteristics in mul ...... ommittee on Multiple Sclerosis
@nl
type
label
Fatigue characteristics in mul ...... le Sclerosis (NARCOMS) survey.
@en
Fatigue characteristics in mul ...... ommittee on Multiple Sclerosis
@nl
prefLabel
Fatigue characteristics in mul ...... le Sclerosis (NARCOMS) survey.
@en
Fatigue characteristics in mul ...... ommittee on Multiple Sclerosis
@nl
P2093
P2860
P356
P1476
Fatigue characteristics in mul ...... le Sclerosis (NARCOMS) survey.
@en
P2093
MerriKay Oleen-Burkey
North American Research Committee on Multiple Sclerosis
Olympia Hadjimichael
Timothy Vollmer
P2860
P2888
P356
10.1186/1477-7525-6-100
P577
2008-11-14T00:00:00Z
P5875
P6179
1009699008